logo
episode-header-image
Aug 2020
45m 27s

S&P Inches Closer to a Record High, Puti...

CNBC
About this episode
Jim Cramer and David Faber discuss the boost in stocks as the S&P 500 closes in on a record high. Russia says it has approved a COVID-19 vaccine. President Putin saying, “as far as I know, this morning, for the first time in the world, a vaccine against a new coronavirus infection has been registered.” It’s important to note that no data has been published b ... Show More
Up next
Yesterday
CNBC Investing Club: Cramer’s Morning Take on P&G 7/29/26
Cramer says he's changing course on this consumer stock. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Charitable Trust – and see up cl ... Show More
3m 46s
Yesterday
11AM Hour: The Case for a Rate Hike, CEOs of Mondelēz and Teva on Earnings 7/29/26
Could the Federal Reserve's next move be a rate hike? Renaissance Macro Head of Economics Neil Dutta joins Squawk on the Street to make the case. Plus, Mondelez CEO Dirk Van de Put discusses better-than-expected earnings, consumer demand, and what's driving growth for the maker o ... Show More
42m 54s
Yesterday
10AM Hour: SOFI CEO, Zuckerberg’s AI Vendetta, SK Hynix Results Fail to Impress 7/29/26
SoFi CEO Anthony Noto joins Squawk on the Street after the stock tumbles despite record quarterly net revenue, explaining the results and outlook for the fintech company. Plus, AI skeptic Ed Zitron weighs in on Mark Zuckerberg’s warning that artificial intelligence power is becom ... Show More
43m 25s
Recommended Episodes
Nov 2020
A Vaccine Boost
Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ... Show More
39m 10s
May 2021
Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More
<p>It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ... Show More
58m 18s
Jul 2023
DocuSign CEO, Sprinklr CEO & IRA Winners 7/12/23
<p>Stocks rose, with the S&P 500 and Nasdaq closing at their highest levels since April 2022, and Jim Cramer is breaking down today's market moves. First, Cramer's checking in on pandemic play DocuSign to see how the company is faring with CEO Allan Thygesen. Then, could a sprink ... Show More
45m 20s
Aug 2021
FDA Grants Full Approval of Pfizer-BioNTech Vaccine
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, discusses U.S. regulators granting full approval of the Covid-19 vaccine made by Pfzier and BioNtech, a milestone expected to help bolster the immunization drive. Bloomberg Law Health Care Reporter Shira Stein shares her story Preg ... Show More
36m 24s
Jun 2020
Dow Jumps 461 Points, Off The Charts, Thor CEO, Sorrento CEO
<p>The Dow rose 461 points with the Nasdaq finishing at a record close and Jim Cramer is digging deeper into today's market rally. Then, Cramer's going 'Off The Charts' to take a closer look at Friday's unemployment number and putting it in context. And, could the bull market in ... Show More
46m 48s
Nov 2020
Hello From the Other Side? And Bitcoin Puts in Another Big Week
<p>There’s more positive news on the vaccine front, companies are raising dividends, and earnings guidance has been strong. Corporate America seems to think we’ve gotten past the worst effects of the pandemic, but have we?</p><p>Plus Bitcoin nearing the $19,000 mark after surging ... Show More
22 m
Apr 2022
COVID Outbreaks, Semiconductor GARP Stocks & Off The Charts 4/13/22
The Dow climbed over 300 points after two days of losses, and Jim Cramer is taking investors through the market's gains after yesterday's dip. Next, with the pandemic still weighing on the stock market, Cramer’s checking in with Dr. Eric Topol on the current state of COVID. Then, ... Show More
44m 41s
May 2020
Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions
<p>Positive results from the first US Covid-19 trial raised investors’ hopes of an economic rebound, Chinese self-driving car start-ups have been accelerating pilot projects as US rivals sit idle, and bond investors have hit out at the growing trend of companies reporting “earnin ... Show More
10m 47s
Aug 2021
U.S. To Urge Covid-19 Booster Shots
Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ... Show More
35m 26s
Jul 2025
The Record Run 7/15/25
<p>Frank Holland and the Investment Committee debate the record run, as the Nasdaq and S&P 500 hit fresh all-time highs. The experts discuss how to trade the big banks as they kick off earnings. Josh Brown is back with his “Best Stocks in the Market.” Calls of the Day include 3M, ... Show More
42m 47s